|
|
Blood, 1 June 2007, Vol. 109, No. 11, pp. 4856-4864.
Prepublished online as a Blood First Edition Paper on February 13, 2007; DOI 10.1182/blood-2006-08-043414.
 Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
T cell–dependent survival of CD20+ and CD20– plasma cells in human secondary lymphoid tissue
David R. Withers1,
Claudia Fiorini1,
Randy T. Fischer1,
Rachel Ettinger2,
Peter E. Lipsky2, and
Amrie C. Grammer1
1 B Cell Biology Group and
2 Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health, Bethesda, MD
The signals mediating human plasma cell survival in vivo, particularly within secondary lymphoid tissue, are unclear. Human tonsils grafted into immunodeficient mice were therefore used to delineate the mechanisms promoting the survival of plasma cells. Tonsillar plasma cells were maintained within the grafts and the majority were nonproliferating, indicating a long-lived phenotype. A significant depletion of graft plasma cells was observed after anti-CD20 treatment, consistent with the expression of CD20 by most of the cells. Moreover, anti-CD52 treatment caused the complete loss of all graft lymphocytes, including plasma cells. Unexpectedly, anti-CD3, but not anti-CD154, treatment caused the complete loss of plasma cells, indicating an essential role for T cells, but not CD40-CD154 interactions in plasma cell survival. The in vitro coculture of purified tonsillar plasma cells and T cells revealed a T-cell survival signal requiring cell contact. Furthermore, immunofluorescence studies detected a close association between human plasma cells and T cells in vivo. These data reveal that human tonsil contains long-lived plasma cells, the majority of which express CD20 and can be deleted with anti-CD20 therapy. In addition, an important role for contact-dependent interactions with T cells in human plasma cell survival within secondary lymphoid tissue was identified.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
Y K O Teng, E W N Levarht, R. E M Toes, T. W J Huizinga, and J. M van Laar
Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation
Ann Rheum Dis,
June 1, 2009;
68(6):
1011 - 1016.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Geffroy-Luseau, G. Jego, R. Bataille, L. Campion, and C. Pellat-Deceunynck
Osteoclasts support the survival of human plasma cells in vitro
Int. Immunol.,
June 1, 2008;
20(6):
775 - 782.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Gonzalez-Garcia, B. Rodriguez-Bayona, F. Mora-Lopez, A. Campos-Caro, and J. A. Brieva
Increased survival is a selective feature of human circulating antigen-induced plasma cells synthesizing high-affinity antibodies
Blood,
January 15, 2008;
111(2):
741 - 749.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Medina, C. Segundo, G. Jimenez-Gomez, I. Gonzalez-Garcia, A. Campos-Caro, and J. A. Brieva
Higher maturity and connective tissue association distinguish resident from recently generated human tonsil plasma cells
J. Leukoc. Biol.,
December 1, 2007;
82(6):
1430 - 1436.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. van Laar, M. Melchers, Y. K. O. Teng, B. van der Zouwen, R. Mohammadi, R. Fischer, L. Margolis, W. Fitzgerald, J.-C. Grivel, F. C. Breedveld, et al.
Sustained Secretion of Immunoglobulin by Long-Lived Human Tonsil Plasma Cells
Am. J. Pathol.,
September 1, 2007;
171(3):
917 - 927.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
